Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2025.10.06

Unlocking Chemical Frontiers: IIT Bombay Prof, Debabrata Maiti at Sai Life Sciences

As part of Sai Life Sciences’ efforts to foster knowledge exchange and bring leading voices from niche areas of science and technology to its teams, the company recently hosted Prof. Debabrata Maiti from the Indian Institute of Technology (IIT) Bombay at its R&D campus in Hyderabad for a day of scientific exchange and dialogue.

The program began with a Masterclass on “Unlocking New Chemical Space via Selective Catalysis.” In his talk, Prof. Maiti outlined novel catalytic strategies to achieve site-selective functionalization and expand the boundaries of chemical synthesis. He highlighted how such innovations are opening access to new chemical space, enabling the design of complex molecules with greater precision and efficiency.

This was followed by a Fireside Chat on “Speed Meets Precision: From Idea to Impact in Rethinking What Molecules Can Be.” In a wide-ranging conversation, Prof. Maiti reflected on the evolving landscape of drug discovery, the interplay between academia and industry, and how advances in catalysis and synthetic methodologies can accelerate the journey from research ideas to real-world applications. He emphasized that “there is no real difference between academia and industry — both are about solving problems and being accountable to stakeholders,” while pointing to the strengths each domain can adopt from the other.

Prof. Maiti, a recipient of multiple national and international recognitions for his pioneering work in transition-metal catalysis and sustainable synthetic methodologies, is widely regarded as one of the leading researchers in the field of modern chemistry. His visit brought valuable perspectives on the role of catalysis in driving innovation, while reinforcing the importance of collaboration across research ecosystems. The sessions attracted scientists and researchers across Sai Life Sciences, sparking engaging discussions and offering fresh insights into how catalysis-driven approaches can redefine the possibilities of chemical discovery and development.

Share article

More News

2026.03.10

AI-driven retrosynthesis integrated into Discovery Chemistry

Sai Life Sciences has entered into a collaboration with Chemical.AI, a technology company specialising in computer-aided synthesis design, to integrate an AI-driven retrosynthesis platform into its Discovery Chemistry workflows. The integration enables medicinal chemists to evaluate synthetic routes more rapidly and explore a broader set of feasible pathways during early-stage drug discovery. Retrosynthesis is a […]
Read more

2026.03.10

Structural Biology capabilities launched with X-Ray Crystallography

Sai Life Sciences has introduced integrated structural biology capabilities with the establishment of X-ray protein crystallography workflows to support structure-based drug discovery programs. The platform encompasses end-to-end protein engineering capabilities, including construct design, gene synthesis, and in-house recombinant protein expression and purification. These foundational steps enable generation of high-quality protein material suitable for structural and […]
Read more

2026.03.09

New Medicinal Chemistry block set for inauguration in Hyderabad

A new Medicinal Chemistry block, Unit VIII, is set for inauguration at IKP, Genome Valley, Hyderabad, expanding discovery capacity to meet growing program demand. The four-floor facility spans approximately 100,000 sq. ft. and is designed to support large, multi-disciplinary project teams. It accommodates more than 200 fume hoods and includes a tightly integrated analytical laboratory […]
Read more

2026.03.09

AI-enabled production and material planning platform implemented

Over the past several months, focused AI pilot initiatives have been conducted across operations to evaluate practical applications that strengthen execution. One such initiative is now live across the network: Optimus, an integrated AI-enabled production and material planning platform, implemented at the end of December 2025. Optimus consolidates capacity planning, equipment allocation, and material availability […]
Read more

2026.03.09

Commercial-scale Photo Flow Chemistry successfully executed in Bidar

Commercial-scale flow chemistry has been successfully executed at our API manufacturing site in Bidar for a late-phase program supporting a US-based innovator. This execution builds on prior investments in continuous processing infrastructure at the site, including a 3-litre photo flow reactor equipped with a monochromatic blue LED light source. The platform enables controlled photochemical transformations […]
Read more